Life ScienceCompany
Santen Pharmaceutical M&A Summary
Santen Pharmaceutical has acquired 3 companies, including 1 in the last 5 years. A total of 2 acquisitions came from private equity firms. It has also divested 1 asset.
Santen Pharmaceutical’s largest acquisition to date was in 2016, when it acquired InnFocus for $225M. Santen Pharmaceutical has acquired in 2 different US states, and 2 countries. The Company’s most targeted sectors include healthcare services (34%) and life science (34%).
Santen Pharmaceutical Business Overview
Where is Santen Pharmaceutical headquartered?
Santen Pharmaceutical is headquartered in Osaka, Japan.
What is Santen Pharmaceutical’s revenue?
Santen Pharmaceutical disclosed revenue of 301,965M JPY for 2024 and 279,037M JPY for 2023.
How many employees does Santen Pharmaceutical have?
Santen Pharmaceutical has 3,744 employees.
What sector is Santen Pharmaceutical in?
Santen Pharmaceutical is a life science company.
When was Santen Pharmaceutical founded?
Santen Pharmaceutical was founded in 1890.
M&A Summary
-
M&A Total Activity4
- M&A Buy Activity3
- M&A Sell Activity1
- Total Sectors Invested 3
- Total Countries Invested 2
- M&A Buy/Sell Connections 3
Unlimited Searches
